Inventor
Krzysztof Chwalisz
Inventor
Berlin, DE
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes29%
C07JSteroids18%
A61BDiagnosis9%
A61NElectrotherapy9%
PatentTitleYear
7,704,983'Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception'20106,844,320'Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor'20056,356,777'Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervix'20026,040,340'Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors'20005,991,649'Methods for activating the muscle cells or nerves of the uterus or cervix'19995,965,529'Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor'19995,962,413'Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor'19995,958,878'Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors'19995,948,762'Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor'19995,895,783'Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor'19995,843,931'6,7-modified 11.beta.-aryl-4-oestrenes'19985,795,881'Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type'19985,744,464'Antigestagens for the inhibition of uterine synthesis of prostaglandin'19985,595,970'Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors'19975,522,877'Methods for measuring uterine electrical and mechanical activity'19965,519,027'D-homo-(16-ene)-11.beta.-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents'19965,446,036'13-alkyl-11beta-phenylgonanes'19955,426,102'14.beta.-H-, 14-and 15-En-11.beta.-aryl-4-oestrenes'19955,418,227'14,16.beta.-ethano-15.beta., 16(1)-cyclo-14.beta.-estra-1,3,5(10)-trienes'19955,397,344'Methods of and apparatus for measuring uterine electrical and mechanical activity'19955,273,971'13-alkyl-11.beta.-phenylgonanes'19935,244,886'11.beta.-phenyl-14.beta.H steroids'19935,132,299'11.beta.-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same'19924,891,368'Use of antigestagens for softening the nonpregnant cervix'19904,888,331'Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–2005Patents assigned to SCHERING AG (23)· patent assignee history
1989–2010Based in Berlin, DE· patent location history
1997–2005Patents assigned to UNIV TEXAS (10)· patent assignee history
2010Patents assigned to EASTERN VIRGINIA MED SCHOOL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING AG | 23 | 1989–2005 |
| UNIV TEXAS | 10 | 1997–2005 |
| EASTERN VIRGINIA MED SCHOOL | 1 | 2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berlin, DE | 25 | 1989–2010 |